Cargando…
Optimal panel of immunohistochemistry for the diagnosis of B-cell non-Hodgkin lymphoma using bone marrow biopsy: a tertiary care center study
BACKGROUND: Morphological diagnosis of non-Hodgkin lymphoma (NHL) is usually based on lymph node biopsy. Bone marrow biopsy (BMB) is important for staging, and morphology alone can be challenging for subtyping. Immunohistochemistry (IHC) allows a more precise diagnosis and characterization of NHL us...
Autores principales: | Marwah, Nisha, Satiza, Manali, Dalal, Niti, Atri, Sudhir, Gupta, Monika, Singh, Sunita, Sen, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987479/ https://www.ncbi.nlm.nih.gov/pubmed/33504685 http://dx.doi.org/10.5045/br.2021.2020146 |
Ejemplares similares
-
Comparison of bone marrow aspiration cytology with bone marrow trephine biopsy histopathology: An observational study
por: Gilotra, Meenu, et al.
Publicado: (2017) -
Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma
por: Benckendorff, Julian, et al.
Publicado: (2021) -
Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group
por: Cerci, Juliano Júlio, et al.
Publicado: (2018) -
Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin’s or Non-Hodgkin’s Lymphoma?
por: Çetin, Güven, et al.
Publicado: (2015) -
The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics
por: Kilsdonk, Melvin, et al.
Publicado: (2022)